Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion type Assertion NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_head.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion description "[The epidermal growth factor receptor (EGFR) is a tyrosine kinase (TK) involved in the tumour progression of many cancer types and may serve as an important therapeutic target (erlotinib, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_provenance.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion evidence source_evidence_literature NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_provenance.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion SIO_000772 20840671 NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_provenance.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion wasDerivedFrom befree-20140225 NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_provenance.
- NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_assertion wasGeneratedBy ECO_0000203 NP681157.RArdW2UJsU__0cuJwtP6tobG6bLL0OX-EwgZGbs6ln5t8130_provenance.